[1]
Mohammad Alabdali, M. et al. 2024. Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients. Journal of Clinical Medicine Research. 16, 11 (Dec. 2024), 527–535. DOI:https://doi.org/10.14740/jocmr6054.